test

Ilko Menkov

@Vestal Point Capital, Lp

Latest period2024 - Q3ReportedManaged Assets$1.319BTotal holdings69
Assets growth rate-1.67%Assets growth rate (2-Q avg)4.62%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Vestal Point Capital, Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 69 positions.

Assets under management

The assets under management (AUM) of Vestal Point Capital, Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.319B in assets, with a quarterly growth rate of -1.67% and a 2-quarter average growth rate of 4.62%. The portfolio is managed by Ilko Menkov, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
AGIOAgios Pharmaceuticals Inc
Recent Activity
New Position
2.57%
$33.767M
760,000 shares@ $44.43 avg price
BMRNBiomarin Pharmaceutical Inc
Recent Activity
New Position
2.14%
$28.116M
400,000 shares@ $70.29 avg price
AVDLAvadel Pharmaceuticals Plc
Recent Activity
New Position
1.99%
$26.23M↓ Put
2M shares@ $13.12 avg price
BHVNBiohaven Ltd
Recent Activity
New Position
1.9%
$24.985M↑ Call
500,000 shares@ $49.97 avg price
EWEdwards Lifesciences Corp
Recent Activity
New Position
1.38%
$18.147M
275,000 shares@ $65.99 avg price
GILDGilead Sciences Inc
Recent Activity
New Position
1.28%
$16.768M
200,000 shares@ $83.84 avg price
AAgilent Technologies Inc
Recent Activity
New Position
1.13%
$14.848M
100,000 shares@ $148.48 avg price
GSKGsk Plc
Recent Activity
New Position
0.94%
$12.264M
300,000 shares@ $40.88 avg price
BCAXBicara Therapeutics Inc
Recent Activity
New Position
0.83%
$10.825M
425,000 shares@ $25.47 avg price
CRNXCrinetics Pharmaceuticals Inc
Recent Activity
New Position
0.8%
$10.476M
205,000 shares@ $51.1 avg price